相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M. Li et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Epigenetics in cancer stem cells
Tan Boon Toh et al.
MOLECULAR CANCER (2017)
Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
Wenyong Long et al.
FRONTIERS IN PHARMACOLOGY (2017)
Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
David M. Walter et al.
CANCER RESEARCH (2017)
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma
T. H. Ho et al.
ONCOGENE (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Genomic Aberrations Frequently Alter Chromatin Regulatory Genes in Chordoma
Lu Wang et al.
GENES CHROMOSOMES & CANCER (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
Chao Lu et al.
SCIENCE (2016)
SETD2: an epigenetic modifier with tumor suppressor functionality
Jun Li et al.
ONCOTARGET (2016)
Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma
Weisi Liu et al.
MEDICINE (2015)
Mutational landscape and clonal architecture in grade II and III gliomas
Hiromichi Suzuki et al.
NATURE GENETICS (2015)
The role of epigenetics in kidney malignancies
Alfredo Harb-De la Rosa et al.
CENTRAL EUROPEAN JOURNAL OF UROLOGY (2015)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
A histone H3K36 chromatin switch coordinates DNA double-strand break repair pathway choice
Chen-Chun Pai et al.
NATURE COMMUNICATIONS (2014)
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
Adam M. Fontebasso et al.
ACTA NEUROPATHOLOGICA (2013)
The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
Feng Li et al.
CELL (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Roel H. Wilting et al.
DRUG RESISTANCE UPDATES (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease
Jill S. Butler et al.
EPIGENOMICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma
Gerben Duns et al.
CANCER RESEARCH (2010)
Histone modifying enzymes: Structures, mechanisms, and specificities
Ronen Marmorstein et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes
Ping Xie et al.
CELLULAR SIGNALLING (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
C Hunter et al.
CANCER RESEARCH (2006)
分享论文
